Hostname: page-component-669899f699-rg895 Total loading time: 0 Render date: 2025-04-28T05:05:04.717Z Has data issue: false hasContentIssue false
  • English
  • Français

Immune System Response in Alzheimer'sDisease

Published online by Cambridge University Press:  18 September 2015

P.L. McGeer ,
H. Akiyama ,
S. Itagaki  and
E.G. McGeer
P.L. McGeer
Affiliation:
Kinsmen Laboratory of Neurological Research, Department of Psychiatry, University of B.C., Vancouver
H. Akiyama
Affiliation:
Kinsmen Laboratory of Neurological Research, Department of Psychiatry, University of B.C., Vancouver
S. Itagaki
Affiliation:
Kinsmen Laboratory of Neurological Research, Department of Psychiatry, University of B.C., Vancouver
E.G. McGeer*
Affiliation:
Kinsmen Laboratory of Neurological Research, Department of Psychiatry, University of B.C., Vancouver
*
Kinsmen Laboratory, University of B.C., 2255 Wesbrook Mall, Vancouver, British Columbia, Canada V6T 1W5
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Involvement of the immune system in the pathogenesis of Alzheimer's disease was demonstrated in two ways: by the attachment of complement proteins to diseased tissue, and by the activation of cells associated with the immune system. Alzheimer brain tissue was stained immunohistochemically by antibodies to components of the classical, but not the alternative, complement pathway. Antibodies to Clq, C3d, and C4d stained senile plaques, dystrophic neurites, neuropil threads and some tangled neurons. Antibodies to a neoantigenic site on the C5b-9 membrane attack complex stained dystrophic neurites and many tangled neurons, but not senile plaques. Antibodies to Factor P and fraction Bb of Factor B, which are specific for the alternative complement pathway, did not stain Alzheimer brain tissue. The cellular immune response was evaluated by the presence of reactive microglia and by the infiltration of small numbers of T-cells into diseased brain tissue. Reactive microglia were identified by antibodies to HLA-DR, a class II major histocompatibility complex glycoprotein, and by enhanced staining with antibodies to leukocyte common antigen and the FC7RI and FcyRII receptors. T-cells were identified by antibodies to leukocyte common antigen, as well as the CD4 and CD8 surface proteins. Double immunostaining with antibodies to GFAP and MHC class I or class II antigens established that astrocytes, which are GFAP positive, do not express MHC antigens in Alzheimer's disease. Endothelial cells express MHC class I antigens while reactive microglia and some leukocytes express class II antigen.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 16 , Issue S4 , November 1989 , pp. 516 - 527
Copyright
Copyright © Canadian Neurological Sciences Federation 1989

References

REFERENCES

1.Ishii, T, Haga, S, Shimizu, F. Identification of components of immunoglobulins in senile plaques by means of fluorescent antibody technique. Acta Neuropathol (Beri) 1975; 32: 157–162.CrossRefGoogle ScholarPubMed
2.Ishii, T, Haga, S. Immuno-electron microscopic localization of immunoglobulins in amyloid fibrils of senile plaques. Acta Neuropathol (Beri) 1976; 20: 372–378.Google Scholar
3.Ishii, T, Haga, S. Immuno-electron microscopic localization of complements in amyloid fibrils of senile plaques. Acta Neuropathol (Beri) 1984; 63: 296–300.CrossRefGoogle ScholarPubMed
4.Ishii, T, Haga, S, Kametani, F. Presence of immunoglobulins and complements in the amyloid plaques in the brain of patients with Alzheimer’s disease. In: Pouplard-Barthelaix, A, Emile, J, Christen, Y, eds. Berlin Heidelberg: Springer-Verlag, 1988: 1729.Google Scholar
5.lhara, Y, Kurizaki, H, Nukina, N, et al. Presence of immunoglobulin light chain in the cores of senile plaques - an unlabelled antibody peroxidase–antiperoxidase (PA) study. Neurol Med (Japan) 1981; 15: 292–295.Google Scholar
6.Eikelenboom, P, Stam, FC. Immunoglobulins and complement factors in senile plaques. Acta Neuropathol (Beri) 1982; 57: 239–242.CrossRefGoogle ScholarPubMed
7.Powers, JM, Schlaepfer, WW, Willingham, MC, et al. An immunoperoxidase study of senile cerebral amyloidosis with pathogenetic considerations.J Neuropathol Exp Neurol 1981; 40: 592–612.CrossRefGoogle ScholarPubMed
8.Eikelenboom, P, Hack, CE, Rozemuller, JM, et al. Complement activation in amyloid plaques in Alzheimer’s dementia. Virchows Archiv [Cell Pathol] 1980; 56: 259–262.CrossRefGoogle Scholar
9.Alafuzoff, I, Adolfsson, R, Grundke-Iqbal, I, et al. Blood-brain barrier in Alzheimer dementia and in non-demented elderly. Acta Neuropathol (Beri) 1987; 73: 160–166.CrossRefGoogle ScholarPubMed
10.Mann, DMA, Yates, PO, Hawkes, J. Plaques and tangles and transmitter deficiencies in dementia. J Neurol Neurosurg Psychiatry 1982; 45: 563–564.CrossRefGoogle ScholarPubMed
11.Pouplard-Barthelaix, A. Immunological markers and neuropathological lesions in Alzheimer’s disease. In: Pouplard-Barthelaix, A, Emile, J, Christen, Y, eds. Berlin Heidelberg: Springer-Verlag, 1988: 7–16.CrossRefGoogle Scholar
12.Cooper, NR. The complement system. In: Stites, DP, Stobo, JD, Wells, JV, eds. Basic and Clinical Immunology, 6th ed. Norwalk: Appleton & Lange, 1987: 114–127.Google Scholar
13.Lampson, LA. Molecular bases of the immune response to neural antigens.TINS 1987; 10: 211–216.Google Scholar
14.McGeer , PL, McGeer, EG, Itagaki, S, et al. Anatomy and pathology of the basal ganglia. Can J Neurol Sci 1987; 14: 363–372.CrossRefGoogle ScholarPubMed
15.McGeer, PL, Itagaki, S, Tago, H, et al. Reactive microglia in patients with senile dementia of the Alzheimer’s type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett 1987; 79: 195–200.CrossRefGoogle ScholarPubMed
16.Rogers, J, Luber-Narod, J, Styren, SD, et al. Expression of immune system-associated antigen by cells of the human central nervous system. Relationship to the pathology of Alzheimer–s disease. Neurobiol Aging 1988; 9: 330–349.Google ScholarPubMed
17.Itagaki, S, McGeer, PL, Akiyama, H, et al. Relationship of microglia and astrocytes to amyloid deposits in Alzheimer’s disease. J Neuroimmunol (in press).Google Scholar
18.Stites, DP, Stobo, JD, Wells, JV. Basic and Clinical Immunology, 6th ed. Norwalk: Appleton & Lange, 1987.Google Scholar
19.Itagaki, S. McGeer, PL, Akiyama, H. Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer’s disease brain tissue. Neurosci Lett 1988; 91: 259–264.CrossRefGoogle ScholarPubMed
20.Luber-Narod, J, Rogers, J. Immune system associated antigens expressed by cells of the human central nervous system. Neurosci Lett 1988; 94: 17–22.CrossRefGoogle ScholarPubMed
21.Rother, K, Till, GO, eds. The Complement System. Berlin, Heidelberg: Springer-Verlag, 1988.CrossRefGoogle Scholar
22.Ikeda, SI, Allsop, D, Glenner, GG. Morphology and distribution of plaque and related deposits in the brains of Alzheimer’s disease and control cases. Lab Invest 1989; 60: 113–119.Google ScholarPubMed
23.Ogomori, K, Kitamoto, T, Tateishi, J, et al. ß-Protein amyloid is widely distributed in the central nervous system of patients with Alzheimer’s disease. Am J Pathol 1989; 134: 243–251.Google Scholar
24.Yamaguchi, H, Hirai, S, Morimatsu, M, et al. A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by ß protein immunostaining. Acta Neuropathol 1988; 76: 541–549.CrossRefGoogle Scholar
25.Wisniewski, HM, Terry, RD. Reexamination of the pathogenesis of the senile plaque. In: Zimmer, HM, ed. Progress in Neuropathology. New York: Grune and Stratton, 1973: 1–26.Google Scholar
26.Braak, H, Braak, E. Neuropil threads occur in dendrites of tangle bearing nerve cells. Neuropathol Appi Neurobiol 1988; 14: 3944.Google ScholarPubMed
27.Fanger, MW, Shen, L, Graziano, RF, et al. Cytotoxicity mediated by human Fc receptors for IgG. Immunol Today 1989; 10: 92–99.CrossRefGoogle ScholarPubMed
28.Gaskin, F, Kingsley, BS, Fu, SM. Autoantibodies to neurofibrillary tangles and brain tissue in Alzheimer’s disease. J Exp Med 1987; 165: 245–250.CrossRefGoogle ScholarPubMed
29.Singh, VK, Fudenberg, HH. Detection of brain autoantibodies in the serum of patients with Alzheimer’s disease but not Down’s syndrome. Immunol Lett 1986; 12: 277–280.CrossRefGoogle Scholar
30.Foley, P, Bradford, HF, Docherty, M, et al. Evidence for the presence of antibodies to cholinergic neurons in the serum of patients with Alzheimer’s disease. J Neurol 1988; 235: 466–471.CrossRefGoogle ScholarPubMed
31.Fillit, H, Luine, VN, Reisberg, B, et al. Studies of the specificity of antibrain antibodies in Alzheimer’s disease. In: Hutton, JT, Kenny, AD, eds. Senile Dementia of the Alzheimer’s Type. New York: Liss, 1985: 307–318.Google Scholar
32.Chapman, J, Bachar, O, Korczyn, AD, et al. Antibodies to cholinergic neurons in Alzheimer’s disease. J Neurochem 1988; 51: 479–485.CrossRefGoogle ScholarPubMed
33.McRae-Degueurce, A, Booj, S, Haglid, K, et al. Antibodies in cerebrospinal fluid of some Alzheimer disease patients recognize cholinergic neurons in the rat central nervous system. Proc Natl Acad Sci USA 1987; 84: 9214–9218.CrossRefGoogle ScholarPubMed